Login / Signup

The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer.

Shenghui He
Published in: Signal transduction and targeted therapy (2020)
Keyphrases
  • crispr cas
  • cell therapy
  • endothelial cells
  • stem cells
  • mesenchymal stem cells
  • clinical trial
  • study protocol
  • gene expression
  • pluripotent stem cells
  • genome wide